Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 241 to 250 of 1514 total matches.
Generic Topical Corticosteroids
The Medical Letter on Drugs and Therapeutics • May 06, 1988 (Issue 765)
Aristocort 0.1% cream.
The Medical Letter, Vol. 30 (Issue 765) May 6, 1988, pp. 49-50
Copyright ...
Since the last Medical Letter review of generic drugs (Volume 28, page 1, 1986), the prediction that generic drugs newly approved in the USA under more relaxed federal regulations will probably be as reliable as brand-name drugs has generally been accurate. Few well-documented generic product failures have been reported. Recently, however, the equivalence of generic topical corticosteroids has been questioned.
Methylphenidate Revisited
The Medical Letter on Drugs and Therapeutics • May 06, 1988 (Issue 765)
).
The Medical Letter, Vol. 30 (Issue 765) May 6, 1988, pp. 51-52
Copyright The Medical Letter
UNAUTHORIZED ...
Methylphenidate (Ritalin and others), a Schedule II controlled substance in the USA, is a short-acting central-nervous-system stimulant widely used for treatment of children with school performance or behavior problems, or what is now called Attention Deficit-Hyperactivity Disorder, or AD-HD (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, third ed., revised [DSM-III R], Washington, DC:authors, 1987, p 50). Some studies have estimated that more than 3% of elementary school students are taking methylphenidate, and one parents' group has brought a...
Ektachem DT Analyzers For The Office
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988 (Issue 782)
Chem,
The Medical Letter, Vol. 30 (Issue 782) December 30, 1988 pp. 119-120
Copyright The Medical ...
(Kodak) perform clinical chemistry tests using desk-top instruments, microliter samples and postage-stamp-sized analytical slides containing dry reagents layered on clear polyester and mounted in plastic. The system requires no wet reagents, except for electrolyte determinations, and is designed to require a minimum amount of training to operate. A single analysis takes about five minutes.
Trimetrexate
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989 (Issue 784)
in previously untreated patients are in progress.
The Medical Letter, Vol. 31 (Issue 784) January 27, 1989, pp ...
Trimetrexate glucuronate (Parke-Davis), an investigational drug, is now available in the USA from the National Institute of Allergy and Infectious Diseases (NIAID) for treatment of selected AIDS patients with Pneumocystis carinii pneumonia (PCP). For this indication, trimetrexate is always used concurrently with leucovorin (Wellcovorin; and others).
Photoplex - A Broad Spectrum Sunscreen
The Medical Letter on Drugs and Therapeutics • Jun 16, 1989 (Issue 794)
, padimate O alone or a combination of 7%
The Medical Letter, Vol. 31 (Issue 794) June 16, 1989, pp. 59-60 ...
Photoplex (Herbert), a new sunscreen formulation containing 7% padimate O and 3% Parsol 1789, is being advertised as the first and only chemical sunscreen with proven absorption throughout the UVB and UVA spectrum.
The Reflotron For Office Chemistry
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989 (Issue 802)
The Medical Letter, Vol. 31 (Issue 802) October 6, 1989, pp. 90-91
Copyright The Medical Letter ...
The Reflotron (Boehringer Mannheim), a desk-top colorimetric reflectance analyzer that weighs 12 pounds, can do clinical chemistry tests on 30 l of whole blood, plasma or serum, using multilayered strips containing dry chemicals. A single test takes two to three minutes.
Treatment of Clostridium Difficile Diarrhea
The Medical Letter on Drugs and Therapeutics • Oct 20, 1989 (Issue 803)
doses and $760 for high doses of oral
Vancocin.
The Medical Letter, Vol. 31 (Issue 803) October 20 ...
The gram-positive bacillus Clostridium difficile is the most common identifiable cause of antibiotic-associated diarrhea and pseudomembranous colitis (R Fekety in GL Mandell et al, eds, Principles and Practice of Infectious Diseases, 3rd ed, New York:Churchill Livingstone, 1990, page 863). C. difficile colitis usually develops during or soon after antibiotic treatment. Virtually any antimicrobial agent can cause the disorder, but clindamycin, ampicillin and the cephalosporins have been implicated most frequently. Pseudomembranous colitis was recently reported in five patients who had ...
Ifosfamide and Mesna
The Medical Letter on Drugs and Therapeutics • Nov 03, 1989 (Issue 804)
are frequent. Stomatitis can occur,
The Medical Letter, Vol. 31 (Issue 804) November 3, 1989, pp. 98-99 ...
Ifosfamide (Ifex - Mead Johnson), a synthetic analog of cyclophosphamide (Cytoxan; and others), has been approved by the US Food and Drug Administration (FDA) for concurrent use with other drugs in third-line chemotherapy of metastatic germ-cell testicular cancer. Given concomitantly, a synthetic sulfhydryl compound known as mesna (Mesnex - Asta) acts in the urine to detoxify metabolites of ifosfamide that cause hemorrhagic cystitis (H Burkert, Cancer Treat Rev, 10 suppl A:175, 1983). Ifosfamide and mesna are available together from Bristol-Myers Oncology Division.
Ethanolamine Oleate For Esophageal Varices
The Medical Letter on Drugs and Therapeutics • Nov 03, 1989 (Issue 804)
Letter, Vol. 31 (Issue 804) November 3, 1989, pp. 99-100
Copyright The Medical Letter
UNAUTHORIZED ...
Endoscopic injection of sclerosing agents is now widely accepted as a primary treatment for bleeding esophageal varices (J Terblanche et al, N Engl J Med, 320:1393, 1469, May 25 and June 1, 1989). Ethanolamine oleate 5% (Ethamolin - Glaxo), a sclerosing agent that has been available in Canada and abroad for many years, was recently approved for this indication by the US Food and Drug Administration (FDA).
Interferon for Chronic Viral Hepatitis
The Medical Letter on Drugs and Therapeutics • Jan 12, 1990 (Issue 809)
Intern Med, 147:1577, 1987; M
Schultz et al, Lancet, 1:1452, 1989).
The Medical Letter, Vol. 32 (Issue ...
Recombinant alpha interferon has been marketed in the USA for treatment of hairy-cell leukemia, genital warts, and AIDS-related Kaposi's sarcoma (Medical Letter, 28:78, 1986; 30:70, 1988). Recent reports indicate it may also be useful for treatment of chronic viral hepatitis. Recombinant alpha interferon is available as alfa-2a (Roferon-A - Roche) or alfa-2b (Intron A - Schering), which are identical except for one amino acid.